One-year access to more than 500 world journals available in the system
-
http://medilib.ir
- Duration of Time : 365 Day
Price : 300$- Special Price : 100$
Individuals With a Family History of Colorectal Cancer Warrant Tailored Interventions to Address Patient-Reported Barriers to Screening.
Jain, Shailavi MD 1; Galoosian, Artin MD 2; Wilhalme, Holly MS 3; Meshkat, Sarah MHA 4; May, Folasade P. MD, PhD, MPhil 1,2,5,6
doi : 10.14309/ctg.0000000000000583
Volume 14(5) pgs. e00583-e00572 May 2023
Population health interventions to increase colorectal cancer (CRC) screening rates often exclude individuals with a family history of CRC, and interventions to increase screening in this high-risk group are rare.
Single-Donor and Pooling Strategies for Fecal Microbiota Transfer Product Preparation in Ulcerative Colitis: A Systematic Review and Meta-analysis.
Levast, Benoit PhD 1; Fontaine, Mathieu PhD 2; Nancey, Stephane MD 3; Dechelotte, Pierre MD 4; Dore, Joel PhD 5; Lehert, Philippe PhD 6,7
doi : 10.14309/ctg.0000000000000568
Patients with ulcerative colitis (UC) have a less diverse microbiome than healthy subjects. Multiple studies have evaluated fecal microbiota transfer (FMT) in these patients using different methods of product preparation, doses, and routes of administration.
Identification of CD8+ T-Cell-Immune Cell Communications in Ileal Crohn's Disease.
Duong, Han G. BS 1,*; Choi, Eunice J. BS 2,*; Hsu, Paul MD, PhD 1,*; Chiang, Natalie R. 1; Patel, Shefali A. BS 1; Olvera, Jocelyn G. BS 1; Liu, Yi Chia BS 1; Lin, Yun Hsuan MS 1; Yao, Priscilla BS 1; Wong, William H. BS 1; Indralingam, Cynthia S. MS 1; Tsai, Matthew S. MD, PhD 1,3; Boland, Brigid S. MD 1; Wang, Wei PhD 2,4; Chang, John T. MD 1,3
doi : 10.14309/ctg.0000000000000576
Crohn's disease (CD) is a major subtype of inflammatory bowel disease (IBD), a spectrum of chronic intestinal disorders caused by dysregulated immune responses to gut microbiota.
Safety and Tolerability of High-Resolution Esophageal Manometry in Children and Adults.
Oh, Janice E. MD, MSc 1; Huang, Lizhou MD 2; Takakura, Will MD 3; Khuu, Kevin BA 4; Wang, Jiajing PhD 5; Kowalewski, Edward BSBA 4; Huang, Shao-Chi BS 4; Chang, Bianca MD 5,6; Pimentel, Mark MD 5,6; Rezaie, Ali MD, MSc 5,6
doi : 10.14309/ctg.0000000000000571
While high-resolution manometry (HRM) is widely accepted as a safe procedure, no study has assessed the safety profile of HRM in clinical practice.
Transarterial Chemoembolization Combined With Apatinib Plus PD-1 Inhibitors for Hepatocellular Carcinoma With Portal Vein Tumor Thrombus: A Multicenter Retrospective Study.
Xia, Wei-Li MD 1; Zhao, Xiao-Hui MD 1; Guo, Yuan MD 1; Hu, Hong-Tao MD 1; Cao, Guang-Shao MD 2; Li, Zhen MD 3; Fan, Wei-Jun MD 4; Xu, Shi-Jun PhD 1; Li, Hai-Liang MD 1
doi : 10.14309/ctg.0000000000000581
The aim of this study was to compare transarterial chemoembolization (TACE) combined with apatinib and PD-1 inhibitors (TACE-AP) with TACE combined with apatinib alone (TACE-A) in the treatment of hepatocellular carcinoma (HCC) with portal vein tumor thrombus (PVTT) and to explore the prognostic factors affecting the survival of patients.
Helicobacter pylori Seropositivity, ABO Blood Type, and Pancreatic Cancer Risk From 5 Prospective Cohorts.
Lee, Alice A. MD 1; Wang, Qiao-Li MD, PhD 2; Kim, Jihye PhD 3; Babic, Ana PhD 2; Zhang, Xuehong MD, ScD 4,5; Perez, Kimberly MD 2; Ng, Kimmie MD, MPH 2; Nowak, Jonathan MD, PhD 6; Rifai, Nader PhD 7; Sesso, Howard D. ScD, MPH 3,8,9; Buring, Julie E. ScD 3,8; Anderson, Garnet L. PhD 10; Wactawski-Wende, Jean PhD 11; Wallace, Robert PhD 12; Manson, JoAnn E. MD, PhD 3,4,8; Giovannucci, Edward L. MD, ScD 3,5; Stampfer, Meir J. MD, DrPH 3,4,5; Kraft, Peter PhD 3,13; Fuchs, Charles S. MD, MPH 14,15; Yuan, Chen ScD 2; Wolpin, Brian M. MD, MPH 2
doi : 10.14309/ctg.0000000000000573
Helicobacter pylori infection may be a risk factor for pancreatic cancer, particularly infection by strains without the cytotoxin-associated gene A (CagA) virulence factor. Non-O blood type is a known risk factor for pancreatic cancer, and H.
Performance of Cytomegalovirus Real-Time Polymerase Chain Reaction Assays of Fecal and Plasma Specimens for Diagnosing Cytomegalovirus Colitis.
Sattayalertyanyong, Onuma MD 1,2; Limsrivilai, Julajak MD, MSc 1; Phaophu, Phutthaphorn MS 1; Subdee, Nichcha BD 1; Horthongkham, Navin PhD 3; Pongpaibul, Ananya MD 4; Angkathunyakul, Napat MD 4; Chayakulkeeree, Methee MD, PhD 5; Pausawasdi, Nonthalee MD 1; Charatcharoenwitthaya, Phunchai MD, MSc 1
doi : 10.14309/ctg.0000000000000574
Cytomegalovirus (CMV) viral load detected by real-time polymerase chain reaction (PCR) in plasma or stool may facilitate detection of CMV colitis.
Social Network Diversity and the Daily Burden of Inflammatory Bowel Disease.
Greene-Higgs, LaVana MD 1; Jordan, Ariel MD 1; Sheehan, Jessica MD, MS 2; Berinstein, Jeffrey MD, MS 2; Admon, Andrew J. MD, MS 3,4; Waljee, Akbar K. MD, MS 2,4; Riehl, Megan PhD 2; Piette, John PhD 4,5; Resnicow, Kenneth PhD 5; Higgins, Peter D. MD, PhD, MS 2; Cohen-Mekelburg, Shirley MD, MS 2,4
doi : 10.14309/ctg.0000000000000572
To examine the association between social network, daily inflammatory bowel disease (IBD) burden, and related cognitive factors such as loneliness and psychological well-being.
